These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 26334954)
1. Plasma N-Glycome Signature of Down Syndrome. Borelli V; Vanhooren V; Lonardi E; Reiding KR; Capri M; Libert C; Garagnani P; Salvioli S; Franceschi C; Wuhrer M J Proteome Res; 2015 Oct; 14(10):4232-45. PubMed ID: 26334954 [TBL] [Abstract][Full Text] [Related]
2. Methylamidation for sialoglycomics by MALDI-MS: a facile derivatization strategy for both α2,3- and α2,6-linked sialic acids. Liu X; Qiu H; Lee RK; Chen W; Li J Anal Chem; 2010 Oct; 82(19):8300-6. PubMed ID: 20831242 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the human seminal plasma glycome reveals the presence of immunomodulatory carbohydrate functional groups. Pang PC; Tissot B; Drobnis EZ; Morris HR; Dell A; Clark GF J Proteome Res; 2009 Nov; 8(11):4906-15. PubMed ID: 19606896 [TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry of proton adducts of fucosylated N-glycans: fucose transfer between antennae gives rise to misleading fragments. Wuhrer M; Koeleman CA; Hokke CH; Deelder AM Rapid Commun Mass Spectrom; 2006; 20(11):1747-54. PubMed ID: 16676317 [TBL] [Abstract][Full Text] [Related]
6. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans. Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139 [TBL] [Abstract][Full Text] [Related]
7. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS. Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729 [TBL] [Abstract][Full Text] [Related]
8. Identification of highly fucosylated N-linked oligosaccharides from the human parotid gland. Guile GR; Harvey DJ; O'Donnell N; Powell AK; Hunter AP; Zamze S; Fernandes DL; Dwek RA; Wing DR Eur J Biochem; 1998 Dec; 258(2):623-56. PubMed ID: 9874230 [TBL] [Abstract][Full Text] [Related]
9. Human serum N-glycan profiles are age and sex dependent. Ding N; Nie H; Sun X; Sun W; Qu Y; Liu X; Yao Y; Liang X; Chen CC; Li Y Age Ageing; 2011 Sep; 40(5):568-75. PubMed ID: 21807702 [TBL] [Abstract][Full Text] [Related]
10. Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Pabst M; Bondili JS; Stadlmann J; Mach L; Altmann F Anal Chem; 2007 Jul; 79(13):5051-7. PubMed ID: 17539604 [TBL] [Abstract][Full Text] [Related]
11. Site-specific N-glycan characterization of human complement factor H. Fenaille F; Le Mignon M; Groseil C; Ramon C; Riandé S; Siret L; Bihoreau N Glycobiology; 2007 Sep; 17(9):932-44. PubMed ID: 17591618 [TBL] [Abstract][Full Text] [Related]
12. Dried blood spot N-glycome analysis by MALDI mass spectrometry. Vreeker GCM; Bladergroen MR; Nicolardi S; Mesker WE; Tollenaar RAEM; van der Burgt YEM; Wuhrer M Talanta; 2019 Dec; 205():120104. PubMed ID: 31450448 [TBL] [Abstract][Full Text] [Related]
13. The N-glycome of human embryonic stem cells. Satomaa T; Heiskanen A; Mikkola M; Olsson C; Blomqvist M; Tiittanen M; Jaatinen T; Aitio O; Olonen A; Helin J; Hiltunen J; Natunen J; Tuuri T; Otonkoski T; Saarinen J; Laine J BMC Cell Biol; 2009 Jun; 10():42. PubMed ID: 19490625 [TBL] [Abstract][Full Text] [Related]
14. N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters. Testa R; Vanhooren V; Bonfigli AR; Boemi M; Olivieri F; Ceriello A; Genovese S; Spazzafumo L; Borelli V; Bacalini MG; Salvioli S; Garagnani P; Dewaele S; Libert C; Franceschi C PLoS One; 2015; 10(3):e0119983. PubMed ID: 25793407 [TBL] [Abstract][Full Text] [Related]
15. Characterization of N-glycans from mouse brain neural cell adhesion molecule. Liedtke S; Geyer H; Wuhrer M; Geyer R; Frank G; Gerardy-Schahn R; Zähringer U; Schachner M Glycobiology; 2001 May; 11(5):373-84. PubMed ID: 11425798 [TBL] [Abstract][Full Text] [Related]
16. MS-based glycomic strategies for probing the structural details of polylactosaminoglycan chain on N-glycans and glycoproteomic identification of its protein carriers. Wang SH; Wu SW; Khoo KH Proteomics; 2011 Jul; 11(14):2812-29. PubMed ID: 21656680 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive glycome profiling of Huntington's disease transgenic mice. Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331 [TBL] [Abstract][Full Text] [Related]
18. High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Reiding KR; Blank D; Kuijper DM; Deelder AM; Wuhrer M Anal Chem; 2014 Jun; 86(12):5784-93. PubMed ID: 24831253 [TBL] [Abstract][Full Text] [Related]
19. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. Saldova R; Asadi Shehni A; Haakensen VD; Steinfeld I; Hilliard M; Kifer I; Helland A; Yakhini Z; Børresen-Dale AL; Rudd PM J Proteome Res; 2014 May; 13(5):2314-27. PubMed ID: 24669823 [TBL] [Abstract][Full Text] [Related]
20. N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. Koles K; van Berkel PH; Pieper FR; Nuijens JH; Mannesse ML; Vliegenthart JF; Kamerling JP Glycobiology; 2004 Jan; 14(1):51-64. PubMed ID: 14514717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]